Jennifer Colavito, OD
Vision Therapy · New York, NYNPI 1699840074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.4% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Among vision therapy clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $32.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$605
- Bausch & Lomb Americas Inc.$445
- Johnson & Johnson Vision Care, Inc.$429
- Oyster Point Pharma, Inc.$298
- Sun Pharmaceutical Industries Inc.$295
- Alcon$294
- plus $426 from 9 others
What the payments were for
- Speaking & faculty fees$2509%
- Food & beverage$2,52390%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 11 | $605 |
| Bausch & Lomb Americas Inc. | 10 | $445 |
| Johnson & Johnson Vision Care, Inc. | 9 | $429 |
| Oyster Point Pharma, Inc. | 14 | $298 |
| Sun Pharmaceutical Industries Inc. | 14 | $295 |
| Alcon | 10 | $294 |
| Tarsus Pharmaceuticals, Inc. | 7 | $181 |
| Novartis | 4 | $97 |
| Harrow Eye, LLC | 1 | $27 |
| Thea Pharma Inc. | 1 | $25 |
| Biotissue Holdings Inc. | 1 | $20 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Kala Pharmaceuticals, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MyDay Contact Lens$250
- INFUSE$146
- Acuvue$139
- MIEBO$125
- TOTAL30$119
How this compares
$2,793 in reported general payments places this provider in the 95th percentile of 22 vision therapy providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 38 | $330 |
Paid to pharmacies, not to this prescriber.
Other vision therapy in New York
- Richard JunNew York$3K
- Daniel HazaiNew York$3K
- Shoshana CraigNew York$1K
- Loganne MikkelsenNew York$392
- Myoung Hee HanNew York$266
- Rima BakhruNew York$156
- Audra SteinerNew York$128
- Allen CohenNew York$122
- Erica SchulmanNew York$107
- Kevin LamNew York$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.